SPRO
Spero Therapeutics, Inc. · Healthcare
CFO, CBO Esther Rajavelu sold $53K of Spero Therapeutics, Inc.
Sold$53,008
$1.31Price
40,596Shares
−10%Stake
What SPRO did after the filing
- The stock from Wed, Nov 13 open, $1.30
- −20.8%
- S&P 500, same days
- −0.1%
Measured over 30 trading days, to the Dec 27 close.
Traded Thu, Nov 7. Filed Tue, Nov 12, 4:05 PM ET, after the close. Returns use the Nov 13 open and the Dec 27 close. Not investment advice.